Strides Pharma Science Limited has informed the Exchange regarding a press release dated December 22, 2022, titled "Receipt of AUD 94 million on account of deferred consideration on the sale of the Company s Australian operations in 2019".
Press Release Dec 22 2022
Filed with NSE ·
6ix hasn’t read this filing yet.
Strides Pharma Science Ltd on 6ix
Earlier from Strides Pharma Science
- Press Release Nov 18 2022
- Press Release Nov 14 2022
- Share Warrants
- Press Release Sep 01 2022
- Press Release Aug 26 2022
Later from Strides Pharma Science
- Press Release Dec 28 2022
- Strides Pharma Science Ltd Press Release Jan 18 2023
- Press Release Jan 20 2023
- Earnings Update_Q3FY23
- Earnings Update_Q2FY23
Follow Strides Pharma Science into a list and get an email when it puts out news.
Follow Strides Pharma Science